Josh Kushner Thrive Capital Management (New York)
Josh Kushner is the founder of Thrive Capital, a technology investment firm spanning venture and public-market exposure. Thrive is known for backing category-defining software and internet companies and for selective public equity ownership. Kushner’s firm sits at the intersection of venture capital and public growth investing followed through filings.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$928M |
| 2 |
Oscar Health
OSCR
|
+$80.7M |
| 3 |
Warby Parker
WRBY
|
+$33M |
| 4 |
Blend Labs
BLND
|
+$5.89M |
| 5 |
Amplitude
AMPL
|
+$74.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Affirm
AFRM
|
+$265M |
| 2 |
Hims & Hers Health
HIMS
|
+$102M |
| 3 |
HIMS.WS
Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an
HIMS.WS
|
+$287K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 67.51% |
| 2 | Technology | 13.94% |
| 3 | Healthcare | 10.96% |
| 4 | Real Estate | 7.6% |
Similar funds
Josh Kushner's Q3 2021 Portfolio in Review
As of Q3 2021, Josh Kushner held 11 positions worth $1.27B, up 56% from $815M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Josh Kushner deployed $680M of net new capital in Q3 2021, opening 5 new positions. Its largest new stake was Robinhood: 20,410,961 shares worth $859M.
By sector, the portfolio is most concentrated in Financials at 68% of assets, up from 33% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Hims & Hers Health, an estimated $102M trimmed.
- Josh Kushner's largest Q3 2021 buy was Robinhood: 20,410,961 shares worth $859M.
- Josh Kushner's biggest Q3 2021 reduction was Hims & Hers Health, cutting an estimated $102M.
- Josh Kushner fully exited Affirm in Q3 2021, selling an estimated $265M.
- Josh Kushner's ten largest holdings make up 100% of its $1.27B portfolio in Q3 2021.
- Josh Kushner opened 5 new positions and closed 2 in Q3 2021.
- Josh Kushner's portfolio value rose 56% quarter-over-quarter to $1.27B.
Based on Thrive Capital Management (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.